Hypertension is the most important modifiable risk factor for all-cause and cardiovascular disease morbidity and mortality. In a departure from the previous guidelines, the 2024 ESC Guidelines on the ...

Abstract and clinical case are now being accepted for ESC Acute CardioVascular Care 2027. Extend the reach of your findings to a global community and gain visibility beyond your local setting.

As a member of the Kosovo Society of Cardiology you are automatically a member of the European Society of Cardiology and the ESC Community.

Our guidelines deliver updated, evidence-based recommendations for managing supraventricular tachycardias – covering drug therapy, ablation, and coexisting conditions.

Heart Failure 2026, organised by the Heart Failure Association of the ESC, brings the global heart failure community to accelerate innovation and translate science into better care. From novel ...

We focus on the molecular, cellular and integrative mechanisms underlying cardiac function and dysfunction. We provide a platform for basic and clinically oriented scientists interested in all aspects ...

Professor Gerald Watts (University of Western Australia - Perth, Australia) presented results from two trials with the APOC3-targeting RNA interference agent, plozasiran, in patients with severe ...

Our close relationships with 50 ESC Affiliated Cardiac Societies outside of Europe and the Mediterranean basin mean advancements in science are shared more effectively.

In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute ...

+ 2027-02-18T08:00 2027-02-20T18:00 Europe/Paris EAPCI 2027 ...

The EACVI CCT Certification programme seeks to set a standard for competency and excellence in the field of cardiac CT across Europe and beyond. It has been meticulously developed to accurately ...